METCALF BRIAN W 4
4 · INCYTE CORP · Filed Apr 13, 2011
Insider Transaction Report
Form 4
INCYTE CORPINCY
METCALF BRIAN W
Chief Drug Discovery Scientist
Transactions
- Sale
Common Stock
2011-04-11$17.42/sh−50,000$871,000→ 66,504 total - Sale
Common Stock
2011-04-11$17.40/sh−50,000$870,000→ 116,504 total - Exercise/Conversion
Non Qualified Stock Option (right to buy)
2011-04-11−82,688→ 0 totalExercise: $5.46Exp: 2016-01-12→ Common Stock (82,688 underlying) - Exercise/Conversion
Common Stock
2011-04-11$5.46/sh+100,000$546,000→ 166,504 total - Exercise/Conversion
Incentive Stock Option (right to buy)
2011-04-11−17,312→ 0 totalExercise: $5.46Exp: 2016-01-12→ Common Stock (17,312 underlying)
Footnotes (1)
- [F1]Beginning January 13, 2006, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.